Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease.
White
Harvey
H
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand. harveyw@adhb.govt.nz
Held
Claes
C
Stewart
Ralph
R
Watson
David
D
Harrington
Robert
R
Budaj
Andrzej
A
Steg
Ph Gabriel
PG
Cannon
Christopher P
CP
Krug-Gourley
Susan
S
Wittes
Janet
J
Trivedi
Trupti
T
Tarka
Elizabeth
E
Wallentin
Lars
L